News
INGN
6.48
-8.09%
-0.57
Weekly Report: what happened at INGN last week (0415-0419)?
Weekly Report · 3d ago
Inogen Announces Executive VP and CMO Departure Plans
TipRanks · 04/15 20:35
Weekly Report: what happened at INGN last week (0408-0412)?
Weekly Report · 04/15 09:18
Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities
Seeking Alpha · 04/13 09:03
Press Release: Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024. The Company will host a conference call at 2:00 p.m. PT on the same day. Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting.
Dow Jones · 04/10 12:31
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)
TipRanks · 04/09 16:10
Needham Reiterates Hold on Inogen
Benzinga · 04/09 15:55
Weekly Report: what happened at INGN last week (0401-0405)?
Weekly Report · 04/08 09:20
Weekly Report: what happened at INGN last week (0325-0329)?
Weekly Report · 04/01 09:19
Weekly Report: what happened at INGN last week (0318-0322)?
Weekly Report · 03/25 09:19
Weekly Report: what happened at INGN last week (0311-0315)?
Weekly Report · 03/18 09:19
Weekly Report: what happened at INGN last week (0304-0308)?
Weekly Report · 03/11 09:19
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Inogen, Inc. Is a medical technology company offering innovative respiratory products for use in the homecare setting. Michael Bourque received equity awards of restricted stock units as a material inducement to enter into employment with Inogen effective March 4, 2024. The awards will vest based on Inogen’s achievement of performance goals.
Barchart · 03/07 15:00
Weekly Report: what happened at INGN last week (0226-0301)?
Weekly Report · 03/04 09:19
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target
Inogen, Inc. Shares are down 29% after the company released its annual report. Revenues were in line with expectations, at US$316m, but statutory losses ballooned to US$4.42 per share. The analysts have updated their forecasts for Inogen's revenues for next year. The company is forecast to grow slower than the broader industry. The average price target for the stock has fallen 19% from US$6.50 to $6.65.
Simply Wall St · 03/01 11:43
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
The Dow Jones index fell around 100 points on Wednesday. U.S. Stocks traded lower toward the end of trading. ADT Inc. Reported better-than-expected earnings for its fourth quarter. Vivani Medical, Inc. Shares shot up 274% to $3.78. Asian markets closed lower in Asia Pacific markets.
Benzinga · 02/28 19:30
BUZZ-U.S. STOCKS ON THE MOVE-Shift4 Payments, Chart Industries, Applied Therapeutics
Wall Street's main indexes slipped on Wednesday. Dow Jones Industrial Average was down 0.10% at 38,933.98. Top three S&P 500 percentage gainers: Axon Enterprise, eBay. The top three Nasdaq percentage losers: Chart Industries, Applied Therapeutics.
Reuters · 02/28 19:26
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ:BMBL) fell sharply after the company reported weak quarterly results. Vivani Medical, Inc. Shares jumped 289% to $3.93 during Wednesday's mid-day session. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate.
Benzinga · 02/28 19:02
Why Is Inogen Stock Plummeting Today?
Inogen Inc reported fourth-quarter 2023 revenues of $75.90 million. The company missed the consensus of $76.99 million. Inogen reported an adjusted EPS loss of $0.83 for the quarter. The medical technology company reported higher revenues than a year ago.
Benzinga · 02/28 18:49
BUZZ-Inogen Inc falls on wider Q4 loss
Shares of medical device maker Inogen Inc fall 34.6% to $6.11. Stock set for biggest one-day pct fall if losses hold. Inogen reported wider Q4 loss of $1.14 per share. Company reported Q4 revenue of $75.90 million.
Reuters · 02/28 18:18
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.